Success Stories: With Premium Processing Upgrade, NIW Approval Made Easy for a Pediatric Resident in Biotechnologies from Greece, Thanks to Our Teamwork
Client’s Testimonial:
“This is fantastic news, thank you so much for your help!!”
On February 22nd, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Pediatrics Resident in the Field of Biotechnologies (Approval Notice).
General Field: Biotechnologies
Position at the Time of Case Filing: Pediatrics Resident
Country of Origin: Greece
State of Residence at the Time of Filing: District of Columbia
Approval Notice Date: February 22nd, 2023
Processing Time: 14 days (Premium Processing Requested)
Case Summary:
An expert in biotechnologies from Greece hired our services for his National Interest Waiver case. He held a Ph.D. in human genetics and was a pediatrics resident with years of experience at his back. His proposed endeavor was to work on the genetic basis and molecular pathogenesis of pediatric disorders to develop novel and efficient diagnostic methods and therapeutic treatments. So while getting his petition together we made a note of the following relevant information:
- His work was of great importance because it provided crucial insight into the genetic mutations and molecular mechanisms underlying the development of a range of rare genetic pediatric disorders and schizophrenia, offering biotechnicians and clinicians the necessary data to develop both effective diagnostic tools and targeted treatment regimens for these conditions.
- This proposed endeavor also had broad implications for the United States since genetic disorders caused by mutations in the DNA are a common cause of pediatric morbidity in the country.
- Due to its clear national importance, his work found funding support from the National Institute of General Medical Sciences, the Burroughs Wellcome Fund, the Louma G Foundation, and the National Institute of Mental Health.
- He had also completed at least 4 reviews to date and his work had resulted in 9 peer-reviewed journal articles (2 of them first-authored and 1 co-first authored).
- His publications have also been cited a total of 162 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of biotechnologies.
- Additionally, he also got 4 letters of recommendation from experts who knew his value and understood the importance of his work for the country. One of them wrote:
These factors and his 4 years of work experience helped a great deal in winning his case quickly. The premium processing upgrade also aided in getting the approval in just 14 days. We thank our client for his trust in our firm and we wish him the best of luck for his future.